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0952-7907 Copyright  2017 WolteZsolt Molnar, Zsolt Szabo, and Marton NemethPurpose of review
To discuss the pathophysiological rationale of advanced hemodynamic monitoring in the critically ill and
also to highlight the importance of a multimodal, individualized approach.
Recent findings
There are several clinical studies and animal experiments evaluating, which hemodynamic endpoint should
be the best target during fluid management. Recent systematic reviews and meta-analyses also investigated
the effects of advanced hemodynamic endpoints targeted hemodynamic management on outcome mainly
in high-risk surgical patients. Although most of these studies report positive results, this knowledge does not
seem to affect our everyday practice. According to large international surveys, most physicians still rely on
inappropriate indices. One of the reasons could be that target values applied in these studies can be
misleading in the individual patient. Therefore, we describe the concept of an individualized approach, in
which normalizing the components of oxygen delivery are put in the context of the patients’ individual
response by evaluating components of oxygen consumption, and organ perfusion.
Summary
Advanced hemodynamic monitoring-based management provides a number of benefits, which could be
better tailored for the patients’ actual needs by putting this into a multimodal, individualized approach.
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DOI:10.1097/ACO.0000000000000440Hemodynamic optimization remains the corner-
stone of resuscitation in the critically ill. Early
recognition of the patients at risk and the imple-
mentation of adequate monitoring guided interven-
tions have profound effects on outcome. Delay or
inadequate management will inevitably lead to
hypoperfusion, tissue hypoxia and multiple organ
failure affecting both outcome andwasting of resour-
ces and costs [1]. Therefore, the use of appropriate
indices,which are able todetect tissuehypoperfusion
and the imbalance between oxygen delivery (DO2)
and oxygen consumption (VO2) is mandatory for
adequatemanagement [2]. Conventional parameters
such as heart rate (HR), mean arterial blood pressure,
mental status and urine output are important warn-
ing signs of inadequate tissue perfusion, but for
detailed assessment advanced hemodynamic
monitoring is warranted [3]. However, recent clinical
studies indicate that there is a considerable gap
between the accumulating knowledge about the
benefits of advanced hemodynamic monitoring-
based optimization and the actual clinical practice.
The results of the FENICE trial, in which fluidht © 2017 Wolters Kluwe
rs Kluwer Health, Inc. All rights resepatients, revealed that the main indicator of admin-
istering fluid boluseswashypotension in 57%, and in
43% of cases no hemodynamic variable was used to
predict fluid responsiveness [4
&&
]. It is basedon strong
pathophysiological rationale that detailed assess-
ment of global hemodynamic indices such as cardiac
output (CO) and derived variables and also the
measures of DO2 and uptake should be taken into
account to provide appropriate therapy for these
patients [5,6]. Furthermore, in addition to the optim-
ization of global hemodynamic parameters,
indicators of tissue perfusion should also be moni-
tored to verify the effectiveness of our interventions
[7]. This multimodal approach requires a paradigm
shift from the current, often arbitrary or protocolized
management, which is often based on predefinedr Health, Inc. All rights reserved.
rved. www.co-anesthesiology.com
KEY POINTS
 Advanced hemodynamic monitoring–targeted treatment
has several benefits in the critically ill.
 Most physicians still use inappropriate indices in their
everyday practice, but treating one single advanced
hemodynamic parameter can also be misleading.
 Therefore, in patients at highest risk a multimodal
approach, taking the components of oxygen delivery
and consumption into account, is mandatory for
adequate assessment and treatment.
 Despite its physiological rationale, whether this
approach has a significant effect on outcome, will have
to be tested in the future.
Intensive care and resuscitationvalues of inappropriate indices and may lead us to
a better, individualized, patient-centered care.
The goal of this review is to highlight the
concept of multimodal, individualized hemody-
namic management in the context of the path-
ophysiological background and the results of
recent trials.PHYSIOLOGICAL ISSUES
Tissue oxygenation is determined by the balance
between the oxygen transport, oxygen demand
and oxygen uptake by the tissues [8]. The main
determinants of DO2 and VO2 and the indicators
of tissue perfusion are depicted in Fig. 1.
When the arterial oxygen content and/or CO
becomes impaired, DO2 decreases, which is often
accompanied by an increase in VO2 mainly due to Copyright © 2017 Wolters Kluwer 
FIGURE 1. Factors affecting oxygen delivery and demand/consu
CvO2, venous oxygen content; DO2, oxygen delivery; Hb, hemog
arterial oxygen saturation; VO2, oxygen consumption. For further
172 www.co-anesthesiology.comthe factors listed in Fig. 1 [9,10]. In the early phase of
decreasing DO2, the circulation can compensate to
some extent, and VO2 remains stable. However,
beyond a critical point, any further drop in DO2
will result in a decrease in VO2. From this point, VO2
becomes dependent on DO2, and aerobic metab-
olism will have to be switched to anaerobic metab-
olism, leading to low ScvO2/SvO2, hyperlactatemia,
metabolic acidosis and oxygen debt [11].
The principle task of early resuscitation is to
regain balance by optimizing the VO2/DO2 ratio.
However, it is also important to define the end-
points of resuscitation to avoid over-resuscitation.
In the case of fluid resuscitation for example,
unnecessary administration of fluids will lead to
hypervolemia, which increases morbidity and
mortality to a similar extent to that of hypovolemia
[12,13]. Unjustified blood transfusions also carry the
risk of hypervolemia and transmission of infections
[14] or allergic reactions [15]. There is evidence that
prolonged use of catecholamines is associated with
poor outcome [16]. Therefore, it is important to
recognize the point when tissue perfusion has nor-
malized, and terminate resuscitation.INDIVIDUALIZED GOAL-DIRECTED
HEMODYNAMIC THERAPY
Themultimodal concept in hemodynamicmonitor-
ing enables us to appreciate that each patient is
different; hence, the so-called normal values, which
are more or less appropriate for a given population,
may be inadequate for the given patient. Therefore,
this concept can be translated into the individual-
ized use of target endpoints to avoid under or over-
resuscitation.Health, Inc. All rights reserved.
mption. CaO2, arterial oxygen content; CO, cardiac output;
lobin; PaO2, arterial partial pressure of oxygen; SaO2,
explanation, see main text.
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Cardiac output and stroke volume as
resuscitation endpoints
In two recent experiments, we investigated CO and
stroke volume (SV) guided hemorrhage and fluid
resuscitation in a porcine model [17,18
&
]. After base-
line measurements, animals were bled until SV
index (SVI) dropped by 50%, after which animals
were resuscitated in four steps till baseline cardaic
index (CI) and SVI values were reached. In the CI-
group, SV, global end diastolic volume and central
venous oxygen saturation (ScvO2) remained signifi-
cantly lower, whereas SV variation (SVV), central
venous-to-arterial carbon dioxide difference (dCO2)
remained significantly higher by the end of resusci-
tation as compared with baseline, indicating that
fluid resuscitation was inadequate and the normal-
ization of CI was mainly due to the persistently
elevated HR, rather than restoration of the circulat-
ing blood volume. On the contrary, in the SVI group
SVV, ScvO2 and dCO2 improved significantly or
returned to their baseline value by the end of the
experiment. Based on these results, it seems that the
SVI-based algorithm resulted in better hemody-
namic and oxygenation indices as compared with
the CI-based approach. This observation certainly
has strong pathophysiological rationale, but it
should be tested in the clinical setting.
Stroke volume variation and pulse pressure
variation as resuscitation endpoints
Recently, less invasive devices, like noncalibrated,
pulse contour analysis-based technologies have been
developedtoassessCObyan invasivearterialpressure
signal. Although these devices are less accurate as
compared with thermodilution-based technologies
as gold standard, there is some evidence that these
methods can adequately show changes and trends in
the hemodynamic status of the patient [19]. Pulse
pressure variation (PPV) and SVV are well established
indicators of fluid responsiveness, and these devices
seem like simple and useful alternatives to invasive
hemodynamic monitoring in several scenarios [20].
The physiological rationale is the following:
mechanical breaths induce heart–lung interactions,
first described by Antonio Maria Valsalva, mainly by
affecting venous return, hence intermittent positive
pressure ventilation can be regarded as a series of
Valsalva-maneuvers. PPV and SVV can reflect these
changes in venous return if tidal volumes are large
enough of 8–10ml/kg of ideal bodyweight [21]. In
addition to the tidal volume, sinus rhythm and no
evidence of right heart failure should also be present
to make PPV/SVV interpretation possible [22].
Increasing intrathoracic pressure will impair venous Copyright © 2017 Wolters Kluwe
0952-7907 Copyright  2017 Wolters Kluwer Health, Inc. All rights resereturn, and after 2–3 heart cycles this will result in a
drop in left ventricular SV, which can be detected by
the cyclic changes of PPV and SVV. In cases of nor-
movolemia, the variation is small (<10%), whereas
on the contrary, values increase in hypovolemia.
In a recent largemulticenter–randomized study,
PPV, MAP and CI-trending-based approach reduced
postoperative complications in high-risk surgical
patients undergoing major abdominal surgery by
almost 50% [23]. A subgroup of patients undergoing
bowel surgery benefited the most from this inter-
vention. In the treatment group 42% of patients
required positive inotropic support, whereas
nobody in the control group was administered
dobutamine. In another clinical trial goal-directed
DO2-therapy was applied in high-risk surgical
patients needing ICU admission after the operation
[24
&&
]. Target DO2 was based on the preoperatively
determined individual DO2 values. In the treatment
group after the first hour of optimization, 40% of
patients received dobutamine as compared with
none in the controls, a very similar result to that
of the previous trial [23]. Their main finding was
that achievement of preoperative DO2 soon after
major surgery was associated with a reduction in
early postoperative morbidity, yet this occurred
irrespective of additional postoperative hemody-
namic management. This was in part due to the fact
that more patients achieved the target DO2 in the
control group (53%) than expected. Their data also
suggested that dobutamine use resulted in the devel-
opment of parasympathetic autonomic dysfunc-
tion, which can potentially be harmful. However,
in two recent meta-analyses, it was found that
patients in the treatment groups received signifi-
cantly more dobutamine, but morbidity and
mortality in general, and also postoperative cardiac
complications were significantly reduced when
advanced hemodynamic monitoring-based intra-
operative management is applied [25,26].
When interpreting the above discussed
parameters at the bedside, it is important to bear
in mind that being for example fluid responsive as
indicated by CI, SVI, SVV or PPV values may not
necessarily mean that the patient need fluid admin-
istration. The results of thesemeasurementsmust be
put into the context of parameters indicating the
patient’s oxygen demand and actual consumption.Parameters reflecting VO2Mixed venous and central venous oxygen
saturation
Mixed venous oxygen saturation (SvO2) and its sur-
rogate, ScvO2 are the most commonly used methodsr Health, Inc. All rights reserved.
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Intensive care and resuscitationto assess global oxygen extraction (VO2/DO2). ScvO2
is an easily obtained parameter via a central venous
catheter already in situ in most critically ill patients,
and it is oftenusedas amarkerof thebalancebetween
DO2 and VO2. The absolute values of ScvO2 are 5%
higher than SvO2 on average, but changes usually
occur in a parallel manner [27]; therefore, ScvO2 is
regarded as a surrogate marker in the clinical setting
[28–30]. However, recent clinical trials, involving
mainly septic patients, were unable to show satisfac-
tory agreement between ScvO2 and SvO2. This could
in part be explained by modifications of blood flow
distribution and oxygen extraction by brain and
splanchnic tissues [31].
The main factors, which influence ScvO2, are
hemoglobin (Hb), arterial oxygen saturation of Hb,
CO and VO2. Theoretically, if three of these factors
are kept constant, the value of ScvO2 reflects the
changes of the latter. There are multiple physio-
logic, pathologic and therapeutic factors that influ-
ence venous oxygen saturation, such as anemia,
hypovolemia, contractility, bleeding, sedation,
fever, pain and others [32].
One of the important features of venous satur-
ations is that it can be pathologic both if it is high
and when it is low. In a recent large cohort of septic
patients in the emergency department, it was found
that mortality was 40% in patients admitted with an
ScvO2 less than 70% but in patients with an initial
ScvO2 of more than 90%, it was almost as high at
34%. The latter was probably due to impaired oxy-
gen utilization [33]. High ScvO2 values may thus
represent an inability of the cells to extract oxygen
or microcirculatory shunting in sepsis [34]. There-
fore, additional measures are necessary to help in
evaluating high ScvO2 values, such as for example
lactate, central venous to arterial dCO2, and
by applying advanced invasive hemodynamic
monitoring.
Lactate
Lactate, the end product on anaerobic metabolism,
has been thoroughly investigated over the last dec-
ades in critically ill patients. It has good prognostic
value in several clinical scenarios such as trauma,
sepsis and high-risk surgical patients [35]. Increased
lactate production is mainly due to anaerobic
metabolism caused by tissue hypoxia. High lactate
concentrations are common findings during the
management of hemodynamically unstable, bleed-
ing patients [36]. Surgical patients admitted to the
ICU with high initial and 24-h lactate levels had
higher mortality compared with patients with nor-
mal levels [37]. Furthermore, there is mounting
evidence that lactate clearance is superior to Copyright © 2017 Wolters Kluwer 
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therapy not only in septic, but also in surgical
patients. Patients with longer duration of high
lactate levels had worse outcome, compared with
patients, who responded to resuscitation and had
declining lactate levels [38]. These results were fur-
ther confirmed by trauma victims, wherein patients
in whom lactate levels normalized within the first
24h, themortality was 10%, as comparedwith those
patients in whom it took 48h, where mortality was
as high as 67% [37]. In a recent experimental hem-
orrhage and resuscitation model on pigs, we found
that considerable changes of lactate level were well
beyond the suggested 6-h time frame [17]. Signifi-
cant increase during and after bleeding and then
significant decreases during resuscitation were
observed between the observation periods of
20min. Therefore, it has some rationale to shorten
the evaluation time periods that would give a faster
signal about the effectiveness of therapy. However, a
confounding factor in the interpretation of declin-
ing lactate levels during resuscitation could be the
diluting effect of the administered fluid. Neverthe-
less, this should be evaluated in the clinical setting.
Venous-to-arterial CO2 gap as therapeutic
endpoint
Another easily obtainable blood flow related blood
gas parameter is the central venous-to-arterial car-
bon dioxide gap. The phenomenon of increased
CO2 during cardiac arrest [38] and cardiopulmonary
resuscitation [39] was first described 30 years ago. As
then, several authors have reported increased dCO2
in different low flow states [40–42]. In oxygen debt
caused anaerobic metabolism, hydrogen ions are
generated through the hydrolysis of ATP to ADP
and increased production of lactic acid [43]. These
hydrogen ions are buffered by bicarbonate pre-
sented in the cells, and this process will generate
CO2 production [44]. The Fick principle adapted to
carbon dioxide demonstrates the inverse relation-
ship between the CO and dCO2 [45], in other words
increased levels of dCO2 reflect low flow states. It has
been shown that in sepsis, heart failure and severe
hypovolemia, its value can be elevated [46,47].
In the clinical setting, dCO2 is also a good pre-
dictor of outcome. Preoperatively, patients with
high dCO2 had significantly higher mortality com-
pared with patients with normal values (36.4 versus
4.5%) [48]. High-risk surgical patients admitted to
ICU postoperatively with high dCO2 also developed
more complications. The cut of value was 5.8mmHg
[49
&&
]. A dCO2 more than 5mmHg had 96% sensi-
tivity to predict the occurrence of postoperative
complications in patients with normal (71%)Health, Inc. All rights reserved.
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good inverse correlation with the CO [41], and it has
also been shown to be a good predictor of bad out-
come in patients with septic shock [40]. In cases like
septic shock, when due to microcirculatory or mito-
chondrial defects, oxygen uptake is insufficient,
ScvO2 can be supranormal. Previous studies have
suggested that under such circumstances, the
increased value of dCO2 (>5mmHg) can help the
physician in detecting inadequate flow to the tis-
sues; hence, the complementary use of ScvO2 and
dCO2 is recommended [50–52].
Similarly to what has been noted at end of the
paragraph discussing components of DO2, measures
of VO2 can only be interpreted and understood if we
put them in the context of indices of DO2. However,
all of the above discussed parameters reflect the
global situation and provide little information of
regional, organ-specific perfusion. For this purpose,
several methods have been developed to gain infor-
mation about the microcirculation.
Microcirculation
In addition to the restoration of macrohemody-
namic indices, themost important task is to normal-
ize DO2 within the microcirculation, especially
when signs of tissue hypoxia, such as increased
lactate, increased dCO2, low or supranormal ScvO2
and organ failure are present. There is mounting
evidence about the microcirculatory derangement
in the critically illmainly in septic shock [53]. Due to
the endothelial dysfunction [54], glycocalyx layer
degradation [55] and pathological cell–endothelial
interactions [56], a condition termed ‘microcircula-
tory shock’ can develop, which can be defined as
‘the failure of microcirculation to support tissue
perfusion and oxygenation, despite normal
systemic hemodynamics’ [57]. Under physiological
circumstances, a dens capillary system forms the
microcirculation, with low heterogeneity in per-
fusion. During severe sepsis, septic shock, there is
an increase in the heterogeneity of capillaries, with
‘no perfusion’ to ‘high perfusion’ in both space and
time [58]. This heterogeneity in perfusion impairs
oxygen transport to the tissues and can lead to organ
failure [59]. It has significant clinical relevance as
among septic patients the proportion of perfused
capillaries as well as heterogeneity index predicts
mortality [60]. As multiple causes can result micro-
circulatory dysfunction, there is no single interven-
tion to restore microcirculation, instead different
therapeutic possibilities should be individualized
on the patients’ needs. Early fluid resuscitation
could increase the proportion of perfused capillaries
and decrease perfusion heterogeneity; however, in
the later phases of therapy, fluid replacement can Copyright © 2017 Wolters Kluwe
0952-7907 Copyright  2017 Wolters Kluwer Health, Inc. All rights reseworsen microcirculation by impairing oxygen
uptake of the cells [61]. Red blood cell transfusion
improved only the severely impaired microcircula-
tion, whereas preserved microcirculation worsened
after transfusion [62]. With the use of vasopressors
after reaching adequate perfusion pressure, micro-
circulation was also restored; however, further
increase in mean arterial pressure did not improve
microcirculation [63]. Positive inotropic agents
improved capillary perfusion with a proportional
decrease in lactate level in critically ill patients [64].
With the development of imaging techniques,
the third generation incident dark field imaging
device [Braedius CytoCam (Braedius Medical BV,
Bikbergerweg 18, 1272 PM Huizen, The Nether-
lands)], which is a hand held device with automatic
analysis program, the evaluation of the microcircu-
lation may be feasible at the bedside. Therefore,
microcirculation-centered therapy may just be on
the doorstep of everyday clinical routine. As the
pathological background of microcirculatory
derangement is multifactorial, an individualized
patient-centered resuscitation should be performed,
and the effectiveness of therapy should also be
evaluated on the level of the microcirculation
[65]. Nevertheless, despite the promising exper-
imental and human research data, its usefulness
in the daily clinical practice has to be tested in
the future.The multimodal concept: pros and cons
One of the most important lessons, what we have
learned from recent clinical trials, is that one single
parameter cannot be used as the only target during
resuscitation. Furthermore, ‘normal’ values or ranges
of certain parameters cannot always be applied for
the individual patient. Therefore, in patients who do
not respond for basic resuscitation and require high
vasopressor support; developed acute respiratory dis-
tress syndromeas part ofmultiple organdysfunction;
have threatening renal failure as part of multiple
organ dysfunction; and are in septic shock, or suf-
fered major trauma and remain unstable after resus-
citation, detailed hemodynamic evaluation-based
management is mandatory to guide treatment better
and to avoid potential harm that unnecessary
therapy can cause. This concept first evaluates the
components of DO2 (Fig. 2). Even if these values are
regarded as normal, whether these are adequate for
the individual patient at the timeofassessment, ithas
to be tested by the patient’s response, which is
summarized in the outer circle of the figure. In the
case of any imbalance, the factors-affecting VO2 have
to be evaluated, normalized if needed, and patient
response to be assessed again.r Health, Inc. All rights reserved.
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FIGURE 2. The ‘hemodynamic disc’. Inner circles: factors
affecting and determining oxygen delivery and consumption.
Outer circle: parameters, which are affected by changes in
oxygen delivery and consumption, which can be assessed at
the bedside. For further explanation, see main text.
Intensive care and resuscitationUnfortunately, these measurements require
special devices, invasive catheters; the evaluation
canbe time-consuming, requireswell trainedperson-
nel, and it is also costly. Therefore, one cannot apply
this strategy for every critically ill patient, and every
parameter may not be required in every patient.
Careful selection of patients at the highest risk but
who would still benefit from this approach, and
also the rationalization of the indices required, is
therefore mandatory to gain the most out of this
management concept.CONCLUSION
Early and adequate hemodynamic stabilization of
the critically ill patients has a significant effect on
outcome. Rather than following certain numbers in
protocols or algorhythms, a multimodal approach,
of assessing hemodynamic variables together with
the balance betweenDO2 and VO2,may help to get a
detailed picture about the hemodynamic status of
our patients and also gives a chance for individu-
alized treatment. One has to appreciate that values
applied as treatment endpoints in clinical studies
and proved beneficial for the study population may
not be adequate for the individual patient. These
important results give the frame what we fine tune
for the patient’s individual needs by putting them in
the context of the complex puzzle of physiology. Copyright © 2017 Wolters Kluwer 
176 www.co-anesthesiology.comThis is what multimodal, individualized hemody-
namic support is all about.
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